002773 康弘药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)11.59314.47714.20913.8047.110
总资产报酬率 ROA (%)10.75313.33112.85812.2196.034
投入资产回报率 ROIC (%)11.55314.40214.05713.5166.877

边际利润分析
销售毛利率 (%)90.32989.52488.92288.55090.164
营业利润率 (%)33.88931.02331.86629.9609.851
息税前利润/营业总收入 (%)32.20128.97629.85729.0759.960
净利润/营业总收入 (%)28.17826.43426.05525.54711.679

收益指标分析
经营活动净收益/利润总额(%)98.08695.56393.23188.628111.772
价值变动净收益/利润总额(%)0.8563.4173.5823.6946.717
营业外收支净额/利润总额(%)-1.625-2.129-2.2001.4499.721

偿债能力分析
流动比率 (X)10.3569.6018.1076.0975.542
速动比率 (X)9.7869.0117.4905.6205.099
资产负债率 (%)7.2957.4408.41510.54112.235
带息债务/全部投入资本 (%)-0.153-0.067-0.149-0.179-0.232
股东权益/带息债务 (%)-65,097.901-148,405.851-66,839.353-55,068.346-41,848.930
股东权益/负债合计 (%)1,273.1411,244.9411,087.270848.043715.530
利息保障倍数 (X)-28.101-20.696-22.569-21.924-10.460

营运能力分析
应收账款周转天数 (天)12.82313.65914.10117.67625.642
存货周转天数 (天)297.789305.027301.598290.659271.703